On ECHEMI
Home > Drugs > Metformin hydrochloride Registered Holders
Metformin hydrochloride structure

Metformin hydrochloride structure

Metformin hydrochloride

Metformin (hydrochloride) is an FDA approved first-line drug for the treatment of type 2 diabetes. Metformin decreases hepatic glucose production, mostly through a mild and transient inhibition of the mitochondrial respiratory-chain complex 1.

Find 58 Related Holders

SOHAN HEALTHCARE PVT. LTD.
European Union European Union

API Registration Country

API Active
Uquifa Mexico S.A.
European Union European Union

API Registration Country

API Active
USV PRIVATE LIMITED
European Union European Union

API Registration Country

API Active
SHANDONG KEYUAN PHARMACEUTICAL CO., LTD.
European Union European Union

API Registration Country

API Active
NINGXIA HENGKANG TECHNOLOGY CO., LTD.
European Union European Union

API Registration Country

API Active
GRANULES INDIA LIMITED
European Union European Union

API Registration Country

API Active
FARMHISPANIA SA
United States United States

API Registration Country

API Active
WANBURY LTD
United States United States

API Registration Country

API Active
SHANGHAI MEDICINAL LTD
United States United States

API Registration Country

API Active
Harman Finochem Ltd
United States United States

API Registration Country

API Active
Recommended Suppliers of Metformin hydrochloride
View 136 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.